Journal: Cell Reports
Article Title: Autism and Schizophrenia-Associated CYFIP1 Regulates the Balance of Synaptic Excitation and Inhibition
doi: 10.1016/j.celrep.2019.01.092
Figure Lengend Snippet:
Article Snippet: Primary antibodies were rabbit anti-CYFIP1 (Upstate, 07-531; ICC, 1:200; WB, 1:1000), mouse anti-GABA A R-β2/3 (Neuromab, MAB341; WB, 1:500), guinea pig anti-GABA A R-γ2 (Synaptic Systems, 224 004; ICC, 1:500), mouse anti-gephyrin (Synaptic Systems, 147 011; ICC, 1:500; IHC, 1:500; WB, 1:500), rat anti-GFP (Nacalai-Tesque, GF090R; ICC, 1:1000), mouse anti-GFP (Neuromab, 73-131; WB, 1:100), mouse anti-GIT1 (Neuromab, N39/B8; WB, 1:500), rabbit anti-Homer (Synaptic Systems, 160 002; ICC, 1:500; WB, 1:500), rabbit anti-neuroligin 2 (Synaptic Systems, 129 202; WB, 1:1000), mouse anti-neuroligin 3 (Neuromab, N110/29; WB, 1:100), mouse anti-PSD95 (Neuromab, K28/43; ICC, 1:500; WB, 1:1000), rabbit anti-β-PIX (Upstate, 07-1450; WB, 1:2000), mouse anti-β-tubulin (Sigma, T5293; WB, 1:1000), rabbit anti-vGAT (Synaptic Systems, 131 003; ICC, 1:1000), guinea pig anti-vGLUT (Synaptic Systems, 135304; ICC, 1:1000), mouse anti-V5 (Invitrogen, R960-25, ICC, 1:1000; WB, 1:1000).
Techniques: Virus, Recombinant, Staining, In Situ, Cloning, shRNA, Plasmid Preparation, Software